Literature DB >> 7432402

Toxic-shock syndrome in menstruating women: association with tampon use and Staphylococcus aureus and clinical features in 52 cases.

K N Shands, G P Schmid, B B Dan, D Blum, R J Guidotti, N T Hargrett, R L Anderson, D L Hill, C V Broome, J D Band, D W Fraser.   

Abstract

To determine the risk factors associated with toxic-shock syndrome (TSS) in menstruating women, we conducted a retrospective telephone study of 52 cases and 52 age-matched and sex-matched controls. Fifty-two cases and 44 controls used tampons (P < 0.02). Moreover, in case-control pairs in which both women used tampons, cases were more likely than controls to use tampons throughout menstruation (42 of 44 vs. 34 of 44, respectively; P < 0.05). There were no significant differences in brand of tampon used, degree of absorbency specified on label, frequency of tampon change, type of contraceptive used, frequency of sexual intercourse, or sexual intercourse during menstruation. Fourteen of 44 cases had one or more definite or probable recurrences during a subsequent menstrual period. In a separate study, Staphylococcus aureus was isolated from 62 of 64 women with TSS and from seven of 71 vaginal cultures obtained from healthy controls (P < 0.001).

Entities:  

Keywords:  Body Temperature; Case Studies; Contraceptive Usage; Data Collection; Diarrhea; Diseases; Equipment And Supplies; Headache; Infections; Interviews; Laboratory Procedures; Measurement; Menstrual Cycle; Menstruation; Population Characteristics; Prevalence; Reproduction; Research Methodology; Retrospective Studies; Sampling Studies; Studies; Survey Methodology; Surveys; Vaginal Tampon--complications; Vomiting

Mesh:

Year:  1980        PMID: 7432402     DOI: 10.1056/NEJM198012183032502

Source DB:  PubMed          Journal:  N Engl J Med        ISSN: 0028-4793            Impact factor:   91.245


  140 in total

Review 1.  Exotoxins of Staphylococcus aureus.

Authors:  M M Dinges; P M Orwin; P M Schlievert
Journal:  Clin Microbiol Rev       Date:  2000-01       Impact factor: 26.132

2.  Reemergence of staphylococcal toxic shock syndrome in Minneapolis-St. Paul, Minnesota, during the 2000-2003 surveillance period.

Authors:  Patrick M Schlievert; Timothy J Tripp; Marnie L Peterson
Journal:  J Clin Microbiol       Date:  2004-06       Impact factor: 5.948

3.  A single, engineered protein therapeutic agent neutralizes exotoxins from both Staphylococcus aureus and Streptococcus pyogenes.

Authors:  Ningyan Wang; Daiva M Mattis; Eric J Sundberg; Patrick M Schlievert; David M Kranz
Journal:  Clin Vaccine Immunol       Date:  2010-09-22

Review 4.  Toxic shock syndrome: a review of the literature.

Authors:  D Thomas; P S Withington
Journal:  Ann R Coll Surg Engl       Date:  1985-05       Impact factor: 1.891

5.  Enhancement of host susceptibility to lethal endotoxin shock by staphylococcal pyrogenic exotoxin type C.

Authors:  P M Schlievert
Journal:  Infect Immun       Date:  1982-04       Impact factor: 3.441

Review 6.  Toxic shock syndrome in Canada.

Authors:  A J Clayton; J E Peacocke; P E Ewan
Journal:  Can Med Assoc J       Date:  1982-04-01       Impact factor: 8.262

7.  Toxic shock syndrome in Utah--1976 to 1983.

Authors:  J A Jacobson; C R Nichols; E M Kasworm
Journal:  West J Med       Date:  1985-09

8.  Nonproduction of toxic shock syndrome toxin 1 by coagulase-negative staphylococci.

Authors:  J Parsonnet; A E Harrison; S E Spencer; A Reading; K C Parsonnet; E H Kass
Journal:  J Clin Microbiol       Date:  1987-08       Impact factor: 5.948

9.  Production of toxic shock syndrome toxin 1 by Staphylococcus aureus as determined by tampon disk-membrane-agar method.

Authors:  R N Robbins; R F Reiser; G L Hehl; M S Bergdoll
Journal:  J Clin Microbiol       Date:  1987-08       Impact factor: 5.948

10.  Staphylococcus aureus triggered reactive arthritis.

Authors:  A R Siam; M Hammoudeh
Journal:  Ann Rheum Dis       Date:  1995-02       Impact factor: 19.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.